EBOVAC3 | Bringing a prophylactic Ebola vaccine to licensure 01-06-2018 - 30-09-2024 Show more information EU-Programme-Call Horizon 2020 H2020-EU.3. SOCIETAL CHALLENGES H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being H2020-EU.3.1.7. Innovative Medicines Initiative 2 (IMI2) H2020-EU.3.1.7.0. Cross-cutting call topics H2020-JTI-IMI2-2015-08-single-stage IMI2-2015-08-01 Ebola and other filoviral haemorrhagic fevers (Ebola+) programme: future outbreaks
PEVIA | PAN EBOLA VACCINE INNOVATIVE APPROACH – Sofia ref.: 116088 01-06-2017 - 31-05-2023 Show more information EU-Programme-Call Horizon 2020 H2020-EU.3. SOCIETAL CHALLENGES H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being H2020-EU.3.1.7. Innovative Medicines Initiative 2 (IMI2) H2020-EU.3.1.7.0. Cross-cutting call topics H2020-JTI-IMI2-2015-08-single-stage IMI2-2015-08-01 Ebola and other filoviral haemorrhagic fevers (Ebola+) programme: future outbreaks
VHFMoDRAD | Viral Haemorrhagic Fever: Modern Approaches for developing bedside Rapid Diagnostics 01-01-2019 - 31-12-2023 Show more information EU-Programme-Call Horizon 2020 H2020-EU.3. SOCIETAL CHALLENGES H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being H2020-EU.3.1.7. Innovative Medicines Initiative 2 (IMI2) H2020-EU.3.1.7.0. Cross-cutting call topics H2020-JTI-IMI2-2015-08-single-stage IMI2-2015-08-01 Ebola and other filoviral haemorrhagic fevers (Ebola+) programme: future outbreaks
VSV-EBOPLUS | SYSTEMS ANALYSIS OF ADULT AND PEDIATRIC RESPONSES TO THE VSV-ZEBOV EBOLA VACCINE - Sofia ref.: 116068 01-04-2016 - 31-03-2023 Show more information EU-Programme-Call Horizon 2020 H2020-EU.3. SOCIETAL CHALLENGES H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being H2020-EU.3.1.7. Innovative Medicines Initiative 2 (IMI2) H2020-EU.3.1.7.0. Cross-cutting call topics H2020-JTI-IMI2-2015-08-single-stage IMI2-2015-08-01 Ebola and other filoviral haemorrhagic fevers (Ebola+) programme: future outbreaks